These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35519234)

  • 21. Evolutionary game analysis of data sharing among large and medium-sized enterprises in the perspective of platform empowerment.
    Li D; Mei X
    Sci Rep; 2024 May; 14(1):11447. PubMed ID: 38769117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Meta-Path-Based Evaluation Method for Enterprise Credit Risk.
    Du M; Ma Y; Zhang Z
    Comput Intell Neurosci; 2022; 2022():1783445. PubMed ID: 36275953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presenteeism in small and medium-sized enterprises: Determinants and impacts on health.
    Knani M; Fournier PS; Biron C
    Work; 2021; 68(3):733-747. PubMed ID: 33612517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Institutional measures and desired supports regarding COVID-19 pandemic among small and medium-sized enterprises: An interview study in Japan].
    Imai T; Moriguchi J; Abe H; Maeda K; Sukegawa M; Shibata E; Nishikido N
    Sangyo Eiseigaku Zasshi; 2022 May; 64(3):137-145. PubMed ID: 34162772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status and future prospects of research and development operations in traditional and complementary and alternative medicine manufacturing small- and medium-sized enterprises: a 2014 company-based survey.
    Ahn M; Park EJ; Woo JM
    Integr Med Res; 2017 Dec; 6(4):409-417. PubMed ID: 29296568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the key factors for small and medium-sized enterprises growth using principal component analysis.
    Ongbali SO; Omotehinse SA; Adams CO; Salawu EY; Afolalu SA
    Heliyon; 2024 Jul; 10(13):e33573. PubMed ID: 39035495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Business Analytics for SME Business Model Transformation under Pandemic Time Pressure.
    Zamani ED; Griva A; Conboy K
    Inf Syst Front; 2022; 24(4):1145-1166. PubMed ID: 35250366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Intelligence and Reduced SMEs' Business Risks. A Dynamic Capabilities Analysis During the COVID-19 Pandemic.
    Drydakis N
    Inf Syst Front; 2022; 24(4):1223-1247. PubMed ID: 35261558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Configurational Analysis of Small and Medium-Sized Enterprises' Radical Innovations: The Perspective of Dynamic Capabilities.
    Tang S; Liao S; Wang L; Chen W; Guo Z
    Front Psychol; 2021; 12():784738. PubMed ID: 35115987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A policy-making model for evolutionary SME behavior during a pandemic recession supported on game theory approach.
    Hafezalkotob A; Nersesian L; Fardi K
    Comput Ind Eng; 2023 Mar; 177():108975. PubMed ID: 36619005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency.
    Carr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):20-3. PubMed ID: 20101799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Assessment of the SME Sector Operations during the COVID-19 Pandemic.
    Grondys K; Ślusarczyk O; Hussain HI; Androniceanu A
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ISO 14001 adoption and environmental performance in small to medium sized enterprises.
    Johnstone L; Hallberg P
    J Environ Manage; 2020 Jul; 266():110592. PubMed ID: 32310124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management practices and their relation to success of Polish SMEs: The empirical verification.
    Łobos K; Wojciech M
    PLoS One; 2021; 16(11):e0259892. PubMed ID: 34780564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the mechanism of barriers towards green finance and public spending in small and medium enterprises from developed countries.
    Chien F; Ngo QT; Hsu CC; Chau KY; Iram R
    Environ Sci Pollut Res Int; 2021 Nov; 28(43):60495-60510. PubMed ID: 34156623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stakeholder pressure and innovation capacity of SMEs in the COVID-19 pandemic: Mediating and multigroup analysis.
    Rubio-Andrés M; Ramos-González MDM; Sastre-Castillo MÁ; Gutiérrez-Broncano S
    Technol Forecast Soc Change; 2023 May; 190():122432. PubMed ID: 36816868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unlocking digital potential: Exploring the drivers of employee dynamic capability on employee digital performance in Chinese SMEs-moderation effect of competitive climate.
    Wang G; Niu Y; Mansor ZD; Leong YC; Yan Z
    Heliyon; 2024 Feb; 10(4):e25583. PubMed ID: 38379974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COVID-19 pandemic's effects on SMEs and travel agencies: The critical role of corporate social responsibility.
    Wang Z; Le TT
    Econ Anal Policy; 2022 Dec; 76():46-58. PubMed ID: 35919271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.